International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.10028180
Original Article
Gene-Xpert: Cutting Edge Technology For Diagnosis of Extrapulmonary-Tuberculosis among Aerobically Sterile Pus & Tissue Samples of Tertiary Care Hospital, Ahmedabad
 ,
 ,
 ,
Published
Oct. 20, 2023
Abstract

Introduction: Diagnosis of Extrapulmonary TB (EPTB) remains a challenge as the number of Mycobacterium tuberculosis (MTB) bacilli present in tissues and pus samples from various sites of disease are often low & non-uniformly distributed. Molecular diagnostic methods like GeneXpert or Cartridge-based nucleic acid amplification test (CBNAAT) seems to hold the key to future of better and efficient diagnosis of Extrapulmonary Tuberculosis (EPTB) in pus and tissue samples as it simultaneously detects M. tuberculosis and Rifampicin resistance in samples.

Material & Methods : A Retrospective cross sectional study was carried out in the Department of Microbiology. This study includes pus and tissue samples from November 2021 to December 2022 – 14 months. All pus and tissue samples were subjected to aerobic culture, simultaneously Gram stain, ZN stain, Modified ZN stain, KOH mount were performed among them. All samples that met the inclusion criteria which were sterile and smear negative (Gram stain, ZN stain, Modified ZN, KOH mount) were subjected to clinical evaluation. In these cases, detailed clinical history for TB were taken and samples were subjected to GeneXpert. Later on data were analysed on the basis of clinically suspected and clinically not suspected for TB.

Inclusion criteria: Frank Pus sample > 3 ml, Tissue minimum 1 gm

Exclusion criteria: Blood-stained Pus, Pus samples < 3 ml, Pus swab, Tissue received in Formalin, Clinical history not available

Results: Total 387 samples (360 pus, 27 tissue) received for aerobic culture. Among them 198 samples (181 pus, 17 tissue) were aerobically sterile and smear negative (Gram stain, Zn stain, Modified ZN, KOH mount). Out of 181 pus samples, 47 samples (13.05%) met the inclusion criteria and were subjected to Gene-Xpert. Among these 15 positive samples, 11 samples (23.40%) were clinically suspected & 4 samples (8.51%) clinically not suspected were detected of M. Tuberculosis. Among 27 tissue samples, 17 sterile and smear negative samples were subjected to Gene-Xpert, among them only 2(11.76%) clinically not suspected samples of Tissue were detected for M. Tuberculosis.

Conclusion: Diagnosis of EPTB is very important as pus and tissue are regarded as precious samples which cannot be repeatedly retrieved. Our data suggest use of GeneXpert for diagnosis of EPTB in smear negative, aerobically sterile pus & tissue samples.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
2906 Views
212 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved